INSIGHTS ON DRUG DEVELOPMENT

• This Is Where Quality Starts

  Quality takes shape long before a workcell ships. Meet the people and processes that ensure consistent performance through every stage of development, and explore how to build reliability into each step.

• Solutions For CQA Analysis Of IVT mRNA-Based Biotherapeutics

  Discover new innovative solutions for mRNA analysis, enhancing accuracy and efficiency in IVT mRNA workflows, including advanced technologies and methodologies to optimize your research and development processes.

• High-Sensitivity IVT mRNA Analysis

  Quality analysis of in vitro transcribed (IVT) has become an essential part of biotherapeutic workflows. Discover a high-sensitivity kit made for analyzing IVT mRNA quality to advance your research.

• Alzheimer's Disease Pathway

  Alzheimer’s disease (AD) affects 50 million people globally, causing cognitive decline. Explore the signaling pathways of amyloid beta and tau proteins, linking them to neuronal death and AD symptoms.

• Why DSC Testing Is A Critical Step In Developing Biosimilar Drugs

  10/3/2024

  Explore the importance of testing in the regulatory process and how tools like Differential Scanning Calorimetry (DSC) are helping to bring more biosimilars to patients in need.

• From Model To Molecule: Combining AI And Experimental Strategies To Transform Drug Development

  3/8/2026

  See how integrating AI-driven predictive modeling with well-designed experimental validation can help overcome development challenges, improve decision-making, and support accurate evaluation of API solid-state properties.

• Why Reshoring Is An Essential Strategy For ADC Supply Chain Security

  2/24/2026

  Biotechs reshoring their supply chains to Western regions to mitigate risk and improve reliability require experienced partners to effectively manage these complex transitions.

• Improved Cell Viability For Multi-Day Cell-Based Assays

  7/24/2025

  Ensure consistent cell health and assay reliability with controlled temperature and gas conditions. Discover how microplate readers with gas mixers enhance cell viability in live cell-based assays.

• Introducing 2 New Highly Effective ADC Payloads For Cancer Therapeutics

  11/6/2024

  Unlock the potential of antibody-drug conjugates (ADCs) by exploring our novel payloads, designed for easy access and evaluation, to accelerate your ADC drug development with proven efficacy and safety.